Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03164629 · ClinicalTrials.gov registry record · NA
3D Rotational CT Angiogram With Embolization Guidance and CBCT in Prostatic Artery Embolization
A NA study of Enlarged Prostate, sponsored by University of Miami.
- Completed
- Registry status
- NA
- Development phase
- 50
- Enrollment target
- 1
- Study location
NCT03164629 is a NA study of Enlarged Prostate that has completed, run by University of Miami. The registered enrollment target is 50 participants. The trial reports 1 study location across 1 state.
The verdict
NCT03164629, a NA study of Enlarged Prostate, has completed, sponsored by University of Miami.
- COMPLETED
- Registry status
- NA
- Development phase
- 50 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this research study is to learn about how cone-beam Computerized Tomography scans (X-ray images taken from different angles) work together with an embolization guidance software (helps the doctor see the arteries that feed the prostate)to find and see arteries in the prostate.
Conditions Studied
Interventions
- DEVICE cone-beam CT 3D Emboguide
Study Locations (1)
Florida
- Professional Arts Center - Miami
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2017-04-17 |
| Est. Completion | 2018-10-19 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03164629
The ClinicalTrials.gov registry entry for NCT03164629 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Miami, which has 721 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Enlarged Prostate appearing as the primary indexed condition, and to 1 intervention - of which cone-beam CT 3D Emboguide is the first listed.
NCT03164629 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.
Frequently Asked Questions
What is clinical trial NCT03164629 about?
NCT03164629 is a clinical study titled "3D Rotational CT Angiogram With Embolization Guidance and CBCT in Prostatic Artery Embolization". The purpose of this research study is to learn about how cone-beam Computerized Tomography scans (X-ray images taken from different angles) work together with an embolization guidance software (helps the doctor see the arteries that feed the prostate)to find and see arteries in the prostate.
What is the current status of trial NCT03164629?
This trial is currently completed. It is a NA study. The enrollment target is 50 participants. The study started on 2017-04-17. Estimated completion is 2018-10-19.
What conditions does trial NCT03164629 study?
This clinical trial studies the following conditions: Enlarged Prostate.
What interventions are being tested in trial NCT03164629?
The interventions under investigation include: cone-beam CT 3D Emboguide (DEVICE).
Who is sponsoring clinical trial NCT03164629?
This trial is sponsored by University of Miami, which has 721 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03164629 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Enlarged Prostate
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.